Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
62.76
+20.82 (49.64%)
At close: Mar 9, 2026, 4:00 PM EDT
62.45
-0.31 (-0.49%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Xenon Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 199.16 | 142.71 | 148.64 | 57.24 | 175.69 | Upgrade
|
| Short-Term Investments | 349.72 | 484.19 | 489.44 | 534.85 | 376.09 | Upgrade
|
| Cash & Short-Term Investments | 548.89 | 626.91 | 638.08 | 592.09 | 551.77 | Upgrade
|
| Cash Growth | -12.45% | -1.75% | 7.77% | 7.31% | 211.74% | Upgrade
|
| Accounts Receivable | 1.37 | 1.47 | 0.87 | 0.99 | 2.77 | Upgrade
|
| Receivables | 1.37 | 1.47 | 0.87 | 0.99 | 2.77 | Upgrade
|
| Prepaid Expenses | 10.39 | 6.89 | 6.01 | 7.23 | 4.48 | Upgrade
|
| Total Current Assets | 560.65 | 635.26 | 644.96 | 600.3 | 559.02 | Upgrade
|
| Property, Plant & Equipment | 15.35 | 18.22 | 18.85 | 16.91 | 12.52 | Upgrade
|
| Long-Term Investments | 37.15 | 127.5 | 292.79 | 128.68 | - | Upgrade
|
| Long-Term Deferred Tax Assets | 12.86 | 9.67 | 0.8 | 0.51 | 0.47 | Upgrade
|
| Other Long-Term Assets | 7.15 | 7.5 | 7.4 | 7.75 | - | Upgrade
|
| Total Assets | 633.16 | 798.14 | 964.8 | 754.15 | 572.01 | Upgrade
|
| Accounts Payable | 3.89 | 5.07 | 8.6 | 8.49 | 3.82 | Upgrade
|
| Accrued Expenses | 36.06 | 23.47 | 17.03 | 13.38 | 9.78 | Upgrade
|
| Current Portion of Leases | 1.53 | 1.37 | 1.3 | 0.49 | 0.61 | Upgrade
|
| Current Income Taxes Payable | 0.31 | 5.69 | 0.35 | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | 0.34 | 0.12 | Upgrade
|
| Total Current Liabilities | 41.79 | 35.59 | 27.27 | 22.7 | 14.32 | Upgrade
|
| Long-Term Leases | 6.41 | 7.65 | 9.6 | 9.95 | 7.65 | Upgrade
|
| Other Long-Term Liabilities | 3.2 | - | - | - | - | Upgrade
|
| Total Liabilities | 51.4 | 43.24 | 36.88 | 32.65 | 21.97 | Upgrade
|
| Common Stock | 1,599 | 1,457 | 1,436 | 1,065 | 790.9 | Upgrade
|
| Additional Paid-In Capital | 228.23 | 199.15 | 156.76 | 142.11 | 117.5 | Upgrade
|
| Retained Earnings | -1,245 | -899.47 | -665.14 | -482.75 | -357.37 | Upgrade
|
| Comprehensive Income & Other | 0.34 | -1.61 | -0.08 | -3 | -0.99 | Upgrade
|
| Shareholders' Equity | 581.76 | 754.9 | 927.92 | 721.5 | 550.03 | Upgrade
|
| Total Liabilities & Equity | 633.16 | 798.14 | 964.8 | 754.15 | 572.01 | Upgrade
|
| Total Debt | 7.94 | 9.02 | 10.9 | 10.44 | 8.26 | Upgrade
|
| Net Cash (Debt) | 578.09 | 745.39 | 919.97 | 710.33 | 543.52 | Upgrade
|
| Net Cash Growth | -22.44% | -18.98% | 29.51% | 30.69% | 212.94% | Upgrade
|
| Net Cash Per Share | 7.29 | 9.57 | 13.75 | 11.73 | 12.46 | Upgrade
|
| Filing Date Shares Outstanding | 83.19 | 76.54 | 75.43 | 63.04 | 52.94 | Upgrade
|
| Total Common Shares Outstanding | 80.01 | 76.42 | 75.37 | 62.59 | 52.65 | Upgrade
|
| Working Capital | 518.86 | 599.67 | 617.69 | 577.6 | 544.7 | Upgrade
|
| Book Value Per Share | 7.27 | 9.88 | 12.31 | 11.53 | 10.45 | Upgrade
|
| Tangible Book Value | 581.76 | 754.9 | 927.92 | 721.5 | 550.03 | Upgrade
|
| Tangible Book Value Per Share | 7.27 | 9.88 | 12.31 | 11.53 | 10.45 | Upgrade
|
| Machinery | 14.76 | 14.38 | 11.89 | 11 | 10.8 | Upgrade
|
| Leasehold Improvements | 9.41 | 9.36 | 9.02 | 4.2 | 7.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.